Stellenbosch University Immunology Research Group
Publications
2014
1. Baumann R, Kaempfer S, Chegou N N, Oehlmann W, Loxton A G, Kaufmann S H E, van Helden P D, Black G F, Singh M and Walzl G. Serologic diagnosis of tuberculosis by combining Ig classes against selected mycobacterial targets. J. Infect. (2014) 69:581-589.
http://www.ncbi.nlm.nih.gov/pubmed/24968240
2. Salie M, van der Merwe L, Möller M, Daya M, van der Spuy G D, van Helden P D, Martin M P, Gao X-J, Warren R M, Carrington M and Hoal E G. Associations between human leukocyte antigen class I variants and the Mycobacterium tuberculosis subtypes causing disease. J. Infect. Dis. (2014) 209:216-223.
http://www.ncbi.nlm.nih.gov/pubmed/23945374
3. Olivier A J, Masson L, Ronacher K, Walzl G, Coetzee D, Lewis D A, Williamson A-L, Passmore J-A S and Burgers W A. Distinct Cytokine Patterns in Semen Influence Local HIV Shedding and HIV Target Cell Activation. J. Infect. Dis. (2014) 209:1174-1184.
http://www.ncbi.nlm.nih.gov/pubmed/24273175
4. Chegou N N, Heyckendorf J, Walzl G, Lange C and Ruhwald M. Beyond the IFN-γ horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis. Eur. Respir. J. (2014) 43:1472-1486.
http://www.ncbi.nlm.nih.gov/pubmed/24311770
5. Nel H J, du Plessis N, Kleynhans L, Loxton A G, van Helden P D and Walzl G. Mycobacterium bovis BCG infection severely delays Trichuris muris expulsion and co-infection suppresses immune responsiveness to both pathogens. BMC Microbiol. (2014) 14:9.
http://www.biomedcentral.com/1471-2180/14/9
6. Essone P N, Chegou N N, Loxton A G, Stanley K, Kriel M, van der Spuy G, Franken K L, Ottenhoff T H and Walzl G. Host cytokine responses induced after overnight stimulation with novel M. tuberculosis infection phase-dependent antigens show promise as diagnostic candidates for TB disease. PLoS ONE (2014) 9:e102584.
http://www.ncbi.nlm.nih.gov/pubmed/25025278
7. Essone P N, Kalsdorf B, Chegou N N, Loxton A G, Kriel M, Preyer R, Ernst M, Walzl G and Lange C. Bifunctional T-cell-derived cytokines for the diagnosis of tuberculosis and treatment monitoring. Respiration (2014) 88:251-261.
http://www.ncbi.nlm.nih.gov/pubmed/25171202
8. Katengua-Thamahane E, Marnewick J L, Ajuwon O R, Chegou N N, Szűcs G, Ferdinandy P�t, Csont T, Csonka C and Van Rooyen J. The combination of red palm oil and rooibos show anti-inflammatory effects in rats. J Inflamm (Lond) (2014) 11:41.
1
9. Kaufmann S H, Cotton M F, Eisele B, Gengenbacher M, Grode L, Hesseling A C and Walzl G. The BCG replacement vaccine VPM1002: from drawing board to clinical trial. Expert Rev Vaccines (2014) 13:619-630.
http://www.ncbi.nlm.nih.gov/pubme
d/24702486
. The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study. Clin. Infect. Dis. (2014) 58:1676-1683.
http://www.ncbi.nlm.nih.gov/pubmed/24647020
11. Masson L, Mlisana K, Little F, Werner L, Mkhize N N, Ronacher K, Gamieldien H, Williamson C, Mckinnon L R, Walzl G, Abdool Karim Q, Abdool Karim S S and Passmore J-A S. Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study. Sex Transm Infect (2014) 90:580-587.
http://www.ncbi.nlm.nih.gov/pubmed/25107710
12. Mihret A, Loxton A G, Bekele Y, Kaufmann S H E, Kidd M, Haks M C, Ottenhoff T H M, Aseffa A, Howe R and Walzl G.Combination of gene expression patterns in whole blood discriminate between tuberculosis infection states. BMC Infect. Dis. (2014) 14:257.
www.biomedcentral.com/1471-2334/14/257
13. Mkhize-Kwitshana Z L, Mabaso M L and Walzl G. Proliferative capacity and cytokine production by cells of HIV-infected and uninfected adults with different helminth infection phenotypes in South Africa. BMC Infect. Dis. (2014) 14:499.
http://www.biomedcentral.com/1471-2334/14/499
14. Ota M O C, Mendy J F, Donkor S, Togun T, Daramy M, Gomez M P, Chegou N N, Sillah A K, Owolabi O, Kampmann B, Walzl G and Sutherland J S. Rapid diagnosis of tuberculosis using ex vivo host biomarkers in sputum. Eur. Respir. J. (2014) 44:254-257.
http://erj.ersjournals.com/content/early/2014/03/13/09031936.00209913.abstract
15. Streicher E M, Maharaj K, York T, Van Heerden C, Barnard M, Diacon A, Mendel C M, Bosman M E, Hepple J A, Pym A S, Warren R M and van Helden P D. Rapid sequencing of the Mycobacterium tuberculosis pncA gene for detection of pyrazinamide susceptibility. J. Clin. Microbiol. (2014) 52:4056-4057.
http://www.ncbi.nlm.nih.gov/pubmed/25165081
16. Sutherland J S, Loxton A G, Haks M C, Kassa D, Ambrose L, Lee J-S, Ran L, van Baarle D, Maertzdorf J, Howe R, Mayanja-Kizza H, Boom W H, Thiel B A, Crampin A C, Hanekom W, Ota M O C, Dockrell H, Walzl G, Kaufmann S H E, Ottenhoff T H M and GCGH Biomarkers for TB consortium . Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity. Clin. Microbiol. Infect. (2014) 20:O230-238.
http://www.ncbi.nlm.nih.gov/pubmed/24205913